Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/OSE-IMMUNOTHERAPEUTICS-21120309/news/OSE-Immunotherapeutics-Presents-Positive-Step-1-Phase-3-Results-for-Tedopi-in-NSCLC-at-the-Europ-31328482/?utm_source=whatsapp&utm_medium=social&utm_campaign=share